Geron (GERN) Reports Q1 Loss, Lags Revenue Estimates

Geron (GERN) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to loss of $0.09 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 25%. A quarter ago, it was expected that this drugmaker would post a loss of $0.02 per share when it actually produced a loss of $0.04, delivering a surprise of -100%. Empirical research shows a strong correlation between near-term ...